Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families
Authors:
- 21 April 2005
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 43 (3) , 309-313
Abstract
Many rearrangement mutations in the BRCA1 gene have been identified. It is becoming clear that some of these mutations are prevalent, and therefore their detection is necessary in order for clinical genetic tests to have high sensitivity. Published information on particular rearrangements is frequently limited to a single patient, small groups of patients, or patients of a particular ethnicity. The objectives of this work included characterizing the prevalence of five specific rearrangement mutations in a large North American patient population. A mutation‐specific multiplex PCR assay was used for determining the prevalence of five BRCA1 rearrangement mutations that previously had been reported to occur in unrelated patients. The mutation status of these rearrangements, which came from 20,712 patients at high risk for hereditary breast and/or ovarian cancers who had submitted specimens for clinical genetic testing, is presented. The results, obtained from 2,634 mutation carriers, showed a 6‐kb duplication of exon 13, identified in 53 patients (2.01%); a 26‐kb deletion encompassing exons 14–20, detected in seven patients (0.27%); a 510‐bp deletion of exon 22, detected in 5 patients (0.19%); and a 3.4‐kb deletion of exon 13, detected in one patient (0.04%). A previously reported 7.1‐kb deletion of exons 8–9 was not found. The high frequency of the exon 13 duplication makes it the fourth most prevalent mutation in these patients. These results provide an accurate picture of the prevalence of these mutations in hereditary breast/ovarian cancer patients undergoing genetic testing in North America.Keywords
This publication has 15 references indexed in Scilit:
- A Multi-Exonic BRCA1 Deletion Identified in Multiple Families through Single Nucleotide Polymorphism Haplotype Pair Analysis and Gene Amplification with Widely Dispersed Primer SetsThe Journal of Molecular Diagnostics, 2005
- Application of haplotype pair analysis for the identification of hemizygous lociJournal of Medical Genetics, 2003
- Rapid detection of novelBRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragmentsHuman Mutation, 2002
- Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1Journal of Medical Genetics, 2001
- The Exon 13 Duplication in the BRCA1 Gene Is a Founder Mutation Present in Geographically Diverse PopulationsThe American Journal of Human Genetics, 2000
- AnAlu-mediated 7.1 kb deletion ofBRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10Genes, Chromosomes and Cancer, 2000
- Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer familiesOncogene, 1999
- BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patientsNature Genetics, 1997
- Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer familyHuman Molecular Genetics, 1997
- Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis.Journal of Medical Genetics, 1996